During the 9 months ended September 30, 2024, the increase in cash was a result of $143,400,000 from investing activities, primarily as a result of our strategic transaction, offset in part by $11,700,000 used in financing activities, which included $10,000,000 for the repayment of our credit facility and $1,600,000 in taxes paid on the settlement of RSU releases and $10,400,000 used in operating activities. Our working capital exiting Q3 2024 was $147,000,000 We strengthened our balance sheet, positioning us to pursue our organic and inorganic growth initiatives. Kirsten will be discussing our overall capital allocation framework, including our $10,000,000 share repurchase program announced today. As of September 30th, our expected net operating cash use over the next 12 months is in the range of $14,000,000 to $16,000,000 excluding an estimated tax payment of $7,000,000 related to our asset sale and any share repurchase activity. In our 10 Q filing, we will be providing a full reconciliation of the year to date cash flows.